Welcome to Imprimis Pharmaceuticals.
Our team is dedicated to delivering high quality, novel, and customizable medicines to physicians and patients at accessible prices. One of our key strategies to execute our business model is the use of compounding pharmacies to formulate and distribute to physicians and patients our proprietary compounded drug formulations and technologies. Through the initiation of customer relationships with our family of offerings, we hope to serve our customers’ needs and in turn grow our business.
Our hope is that through the success of our business, we will reduce healthcare costs and provide Americans access to high quality, novel and previously unavailable medicines.
Thank you for your interest in Imprimis Pharmaceuticals.
Mark L. Baum
Chief Executive Officer
To navigate the realities of the current healthcare economy and solve unmet patient needs through the development and commercialization of proprietary sterile and topical drug formulations.
Imprimis Pharmaceuticals Reports on Third Quarter 2014 Financial Results and Provides Update on Business Developments
Imprimis Pharmaceuticals to Host its Third Quarter 2014 Financial Report Conference Call and Webcast on November 12, 2014